1H-MRS evaluation of metabolism in Alzheimer's disease and vascular dementia.
about
Alzheimer disease: new concepts on its neurobiology and the clinical role imaging will playRegional variations and the effects of age and gender on glutamate concentrations in the human brainHemodynamic and neuropathological analysis in rats with aluminum trichloride-induced Alzheimer's diseaseA longitudinal study of cognition, proton MR spectroscopy and synaptic and neuronal pathology in aging wild-type and AβPPswe-PS1dE9 miceHippocampal neurochemical changes in senescent mice induced with chronic injection of D-galactose and NaNO₂: an in vitro high-resolution NMR spectroscopy study at 9.4T.Advances in high-field magnetic resonance spectroscopy in Alzheimer's diseaseWhat have novel imaging techniques revealed about metabolism in the aging brain?A MRS study of metabolic alterations in the frontal white matter of major depressive disorder patients with the treatment of SSRIsRole of myo-inositol by magnetic resonance spectroscopy in early diagnosis of Alzheimer's disease in APP/PS1 transgenic mice.Other magnetic resonance imaging techniques.N-acetylaspartate, choline, myoinositol, glutamine and glutamate (glx) concentration changes in proton MR spectroscopy (1H MRS) in patients with mild cognitive impairment (MCI).Short echo time proton magnetic resonance spectroscopy in Alzheimer's disease: a longitudinal multiple time point studyTherapeutic Effects of TianDiJingWan on the Aβ 25-35-Induced Alzheimer's Disease Model RatsWays toward an early diagnosis in Alzheimer's disease: the Alzheimer's Disease Neuroimaging Initiative (ADNI).Cigarette Smoke-Induced Alterations in Frontal White Matter Lipid Profiles Demonstrated by MALDI-Imaging Mass Spectrometry: Relevance to Alzheimer's DiseaseCerebral metabolite abnormalities in human immunodeficiency virus are associated with cortical and subcortical volumes.Strategies for molecular imaging dementia and neurodegenerative diseases.Body mass index and magnetic resonance markers of brain integrity in adults.(1)H-MRS metabolites in adults with Down syndrome: Effects of dementiaComparison of analytical mathematical approaches for identifying key nuclear magnetic resonance spectroscopy biomarkers in the diagnosis and assessment of clinical change of diseases.Regional proton magnetic resonance spectroscopy patterns in dementia with Lewy bodies.Structural magnetic resonance imaging-derived biomarkers for Alzheimer's disease.Role of emerging neuroimaging modalities in patients with cognitive impairment: a review from the Canadian Consensus Conference on the Diagnosis and Treatment of Dementia 2012.Insulin Resistance and Neurodegeneration: Progress Towards the Development of New Therapeutics for Alzheimer's Disease.¹H- and ¹³C-NMR spectroscopy of Thy-1-APPSL mice brain extracts indicates metabolic changes in Alzheimer's disease.Tobacco Smoke-Induced Brain White Matter Myelin Dysfunction: Potential Co-Factor Role of Smoking in Neurodegeneration.The effects of repeated endotoxin exposure on rat brain metabolites as measured by ex vivo 1HMRS.Multimodality Imaging Approaches in Alzheimer's disease. Part II: 1H MR spectroscopy, FDG PET and Amyloid PET.An age and gender dependency of metabolite concentrations in basal ganglia in children with spastic diplegia: proton magnetic resonance spectroscopy study.Neurochemical changes in the hippocampus and prefrontal cortex associated with electroacupuncture for learning and memory impairment.1H-MRS assessment of the therapeutic effect of bilateral intraventricular BDNF infusion into APP/PS1 double transgenic mice.Neurochemical correlates of cognitive dysfunction in patients with leukoaraiosis: a proton magnetic resonance spectroscopy study.Glutamate and GABA-metabolizing enzymes in post-mortem cerebellum in Alzheimer's disease: phosphate-activated glutaminase and glutamic acid decarboxylase.
P2860
Q24594531-47B7E8BC-2FD6-40D3-A50B-950FCD6E690EQ24647577-7267D4AB-81C1-47CC-BC6C-4743B6D598D1Q28537832-FBF1B92C-9664-4231-BFEF-4AA3646FDF4CQ30635401-4BA6321E-D031-4F2E-8C1E-9C9297C0FFF2Q30758233-7CD7B5D0-00F8-466A-98DF-4210F08820C1Q30770751-B55F0A34-0C36-4799-A5CA-5A9CF985161BQ30850844-8A643DC5-92FC-4EEE-8A87-139F59DA6416Q30942265-F16BC6F1-1CF5-403B-A787-77F5BE14259CQ33724870-BB4D776F-13B3-4890-B3EF-3F71BF9807FEQ33993466-03456AEA-DA08-4F4F-9FAE-9A240A89A656Q34029600-BDA30195-BBB0-4F6A-8E46-3DA4BB81F704Q34247831-A2C04052-444D-4F6A-9367-3F1B477C4C30Q35169744-9FFE14F6-4716-4FFE-9993-3947CA1EC319Q35781558-983A21F6-8BD0-4267-AE4C-F5CDC17A1B8AQ35912013-9EA40DA6-FDEB-4E41-B781-ACA6FC99006EQ36028974-65198C87-818C-4D7A-8ACD-1347C2CC1E68Q36853915-9B9E181A-3627-44DD-912B-CD91E24E9307Q36889018-C5613564-E336-477F-9DDD-D406DF8B4E0FQ37005407-66C77E2A-0D7A-411A-B458-59AE58841B09Q37366637-8285A4AC-90ED-46A4-B3E5-BA9ACFDD2688Q37652823-2C15BC23-F6CC-4DB9-937D-03C46F6AB904Q37755134-20F34DB4-8A80-4D90-AF05-2FC56559D51AQ38190687-BB27083E-E9D8-4A58-8F09-1983DA1CB6C4Q39042377-7B83C0EB-3781-4AC5-8110-3FF2037058B3Q41288398-171C3644-66BF-46F3-9494-3C267EFE2936Q41566472-D09323A0-21D4-47DF-BE89-42E7467386DEQ42006003-FA188C0C-3385-46EE-A826-04DA78D4FAB2Q45732943-7DDAA52D-744D-455B-9444-E21C9291F54DQ46308365-AA995394-E8D9-4643-9D8D-BD2809E5AB89Q47768870-5005923C-CD46-45F2-98BF-38B3B011EF80Q48212980-663D854F-B3D0-4124-B401-AA6504537F9AQ48298656-B3AE63DC-09A1-4AE2-9CB1-9B59EC686979Q48705096-5EDC8972-EDDC-4D91-87B3-5260D44EF65C
P2860
1H-MRS evaluation of metabolism in Alzheimer's disease and vascular dementia.
description
2004 nî lūn-bûn
@nan
2004 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
1H-MRS evaluation of metabolism in Alzheimer's disease and vascular dementia.
@ast
1H-MRS evaluation of metabolism in Alzheimer's disease and vascular dementia.
@en
type
label
1H-MRS evaluation of metabolism in Alzheimer's disease and vascular dementia.
@ast
1H-MRS evaluation of metabolism in Alzheimer's disease and vascular dementia.
@en
prefLabel
1H-MRS evaluation of metabolism in Alzheimer's disease and vascular dementia.
@ast
1H-MRS evaluation of metabolism in Alzheimer's disease and vascular dementia.
@en
P2860
P1476
1H-MRS evaluation of metabolism in Alzheimer's disease and vascular dementia
@en
P2093
Randall S Jones
P2860
P304
P356
10.1179/016164104225017640
P577
2004-07-01T00:00:00Z